Equus caballus (horse): 100034237
Help
Entry
100034237 CDS
T01058
Symbol
IL1B
Name
(RefSeq) interleukin-1 beta
KO
K04519
interleukin 1 beta
Organism
ecb
Equus caballus (horse)
Pathway
ecb01523
Antifolate resistance
ecb04010
MAPK signaling pathway
ecb04060
Cytokine-cytokine receptor interaction
ecb04064
NF-kappa B signaling pathway
ecb04217
Necroptosis
ecb04380
Osteoclast differentiation
ecb04620
Toll-like receptor signaling pathway
ecb04621
NOD-like receptor signaling pathway
ecb04623
Cytosolic DNA-sensing pathway
ecb04625
C-type lectin receptor signaling pathway
ecb04640
Hematopoietic cell lineage
ecb04657
IL-17 signaling pathway
ecb04659
Th17 cell differentiation
ecb04668
TNF signaling pathway
ecb04750
Inflammatory mediator regulation of TRP channels
ecb04932
Non-alcoholic fatty liver disease
ecb04933
AGE-RAGE signaling pathway in diabetic complications
ecb04936
Alcoholic liver disease
ecb04940
Type I diabetes mellitus
ecb05010
Alzheimer disease
ecb05020
Prion disease
ecb05022
Pathways of neurodegeneration - multiple diseases
ecb05132
Salmonella infection
ecb05133
Pertussis
ecb05134
Legionellosis
ecb05135
Yersinia infection
ecb05140
Leishmaniasis
ecb05142
Chagas disease
ecb05143
African trypanosomiasis
ecb05144
Malaria
ecb05146
Amoebiasis
ecb05152
Tuberculosis
ecb05162
Measles
ecb05163
Human cytomegalovirus infection
ecb05164
Influenza A
ecb05168
Herpes simplex virus 1 infection
ecb05171
Coronavirus disease
ecb05321
Inflammatory bowel disease
ecb05323
Rheumatoid arthritis
ecb05332
Graft-versus-host disease
ecb05417
Lipid and atherosclerosis
ecb05418
Fluid shear stress and atherosclerosis
Brite
KEGG Orthology (KO) [BR:
ecb00001
]
09130 Environmental Information Processing
09132 Signal transduction
04010 MAPK signaling pathway
100034237 (IL1B)
04064 NF-kappa B signaling pathway
100034237 (IL1B)
04668 TNF signaling pathway
100034237 (IL1B)
09133 Signaling molecules and interaction
04060 Cytokine-cytokine receptor interaction
100034237 (IL1B)
09140 Cellular Processes
09143 Cell growth and death
04217 Necroptosis
100034237 (IL1B)
09150 Organismal Systems
09151 Immune system
04640 Hematopoietic cell lineage
100034237 (IL1B)
04620 Toll-like receptor signaling pathway
100034237 (IL1B)
04621 NOD-like receptor signaling pathway
100034237 (IL1B)
04623 Cytosolic DNA-sensing pathway
100034237 (IL1B)
04625 C-type lectin receptor signaling pathway
100034237 (IL1B)
04659 Th17 cell differentiation
100034237 (IL1B)
04657 IL-17 signaling pathway
100034237 (IL1B)
09157 Sensory system
04750 Inflammatory mediator regulation of TRP channels
100034237 (IL1B)
09158 Development and regeneration
04380 Osteoclast differentiation
100034237 (IL1B)
09160 Human Diseases
09172 Infectious disease: viral
05171 Coronavirus disease
100034237 (IL1B)
05164 Influenza A
100034237 (IL1B)
05162 Measles
100034237 (IL1B)
05168 Herpes simplex virus 1 infection
100034237 (IL1B)
05163 Human cytomegalovirus infection
100034237 (IL1B)
09171 Infectious disease: bacterial
05132 Salmonella infection
100034237 (IL1B)
05135 Yersinia infection
100034237 (IL1B)
05133 Pertussis
100034237 (IL1B)
05134 Legionellosis
100034237 (IL1B)
05152 Tuberculosis
100034237 (IL1B)
09174 Infectious disease: parasitic
05146 Amoebiasis
100034237 (IL1B)
05144 Malaria
100034237 (IL1B)
05140 Leishmaniasis
100034237 (IL1B)
05142 Chagas disease
100034237 (IL1B)
05143 African trypanosomiasis
100034237 (IL1B)
09163 Immune disease
05323 Rheumatoid arthritis
100034237 (IL1B)
05321 Inflammatory bowel disease
100034237 (IL1B)
05332 Graft-versus-host disease
100034237 (IL1B)
09164 Neurodegenerative disease
05010 Alzheimer disease
100034237 (IL1B)
05020 Prion disease
100034237 (IL1B)
05022 Pathways of neurodegeneration - multiple diseases
100034237 (IL1B)
09166 Cardiovascular disease
05417 Lipid and atherosclerosis
100034237 (IL1B)
05418 Fluid shear stress and atherosclerosis
100034237 (IL1B)
09167 Endocrine and metabolic disease
04940 Type I diabetes mellitus
100034237 (IL1B)
04936 Alcoholic liver disease
100034237 (IL1B)
04932 Non-alcoholic fatty liver disease
100034237 (IL1B)
04933 AGE-RAGE signaling pathway in diabetic complications
100034237 (IL1B)
09176 Drug resistance: antineoplastic
01523 Antifolate resistance
100034237 (IL1B)
09180 Brite Hierarchies
09183 Protein families: signaling and cellular processes
04052 Cytokines and neuropeptides [BR:
ecb04052
]
100034237 (IL1B)
00536 Glycosaminoglycan binding proteins [BR:
ecb00536
]
100034237 (IL1B)
Cytokines and neuropeptides [BR:
ecb04052
]
Cytokines
Interleukins
100034237 (IL1B)
Glycosaminoglycan binding proteins [BR:
ecb00536
]
Heparan sulfate / Heparin
Cytokines
100034237 (IL1B)
SSDB
Ortholog
Paralog
GFIT
Motif
Pfam:
IL1
IL1_propep
Motif
Other DBs
NCBI-GeneID:
100034237
NCBI-ProteinID:
NP_001075995
UniProt:
Q28386
B1AB80
LinkDB
All DBs
Position
15:complement(16418728..16423922)
Genome browser
AA seq
268 aa
AA seq
DB search
MAAVPDTSDMMTYCSGNENDLFFEEDGPKQMKGSFQDLDLSSMGNGGIQLQFSHQLYNKT
FKHVVSIIVAMEKLKKIPVPCSQAFQDDDLRSLFSVIFEEEPIICDNWDDDYVCDAAVHS
VNCRLRDIYHKSLVLSGACELQAVHLNGENTNQQVVFCMSFVQGEEETDKIPVALGLKEK
NLYLSCGMKDGKPTLQLETVDPNTYPKRKMEKRFVFNKMEIKGNVEFESAMYPNWYISTS
QAEKKPVFLGNTRGGRDITDFIMEITSA
NT seq
807 nt
NT seq
+upstream
nt +downstream
nt
atggcagcagtacccgacaccagtgacatgatgacttactgcagcggcaatgagaatgac
ctgttctttgaggaggatggcccaaaacagatgaagggcagcttccaagacctggacctc
agctccatgggcaatgggggcatccagcttcaattctcccaccaactttacaacaagact
ttcaagcatgtcgtgtcaatcattgtggctatggagaagctgaagaagatacccgttccc
tgctcacaggccttccaggatgatgacttgaggagcctcttttctgtcatctttgaagaa
gaacccatcatctgtgacaactgggatgatgattatgtgtgtgatgcagctgtgcattca
gtgaactgcagactccgggacatataccataaatccctggtgctgtccggtgcatgtgag
ctgcaggctgtccacctcaacggagagaatacaaaccaacaagtggtgttctgcatgagc
tttgtgcaaggagaagaagagactgacaagatacctgtggccttgggcctcaaggaaaag
aacctgtacctgtcttgtgggatgaaagatgggaagcccaccctacagctggagacagta
gaccccaatacttacccaaagaggaaaatggaaaagcgatttgtcttcaacaagatggaa
atcaagggcaacgtggaatttgagtctgcaatgtaccccaactggtacatcagcacctct
caagcagaaaaaaagcctgtcttcctaggaaataccagaggcggccgggacataactgac
ttcatcatggaaatcacctctgcctaa
DBGET
integrated database retrieval system